Patient Square Capital LP
23 holdingsFiling period: 2026-06-30Current AUM: $594.0Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | — | Roivant Sciences Ltd | 8.02M | $283.9M | $283.9M | 47.79% | -145,119 | 2026-06-30 |
| 2 | RVMD | Revolution Medicines Inc | 276.0K | $51.7M | $50.8M | 8.55% | -- | 2026-06-30 |
| 3 | MIRM | Mirum Pharmaceuticals Inc | 260.5K | $30.5M | $21.7M | 3.65% | +30.5K | 2026-06-30 |
| 4 | ABVX | Abivax SA | 206.5K | $27.5M | $17.9M | 3.01% | +85.3K | 2026-06-30 |
| 5 | ONC | Beone Medicines Ltd | 90.0K | $25.7M | $33.4M | 5.62% | +9.5K | 2026-06-30 |
| 6 | — | Pharvaris N V | 671.2K | $23.2M | $23.2M | 3.91% | +178.2K | 2026-06-30 |
| 7 | ARGX | Argenx SE | 23.0K | $21.3M | $20.0M | 3.37% | -13,718 | 2026-06-30 |
| 8 | UTHR | United Therapeutics Corp Del | 37.1K | $20.1M | $22.0M | 3.70% | -- | 2026-06-30 |
| 9 | BLTE | Belite Bio Inc | 110.0K | $16.9M | $15.8M | 2.65% | -6,684 | 2026-06-30 |
| 10 | COGT | Cogent Biosciences Inc | 425.0K | $16.4M | $13.1M | 2.21% | -171,000 | 2026-06-30 |
| 11 | DBVT | Dbv Technologies S A | 909.5K | $14.9M | $9.1M | 1.53% | +215.9K | 2026-06-30 |
| 12 | XENE | Xenon Pharmaceuticals Inc | 220.0K | $13.3M | $7.9M | 1.32% | -7,000 | 2026-06-30 |
| 13 | BNTX | Biontech SE | 134.4K | $12.5M | $11.7M | 1.97% | -- | 2026-06-30 |
| 14 | RCUS | Arcus Biosciences Inc | 355.8K | $11.0M | $6.3M | 1.06% | +160.8K | 2026-06-30 |
| 15 | ELVN | Enliven Therapeutics Inc | 212.5K | $10.8M | $8.8M | 1.48% | +12.5K | 2026-06-30 |
| 16 | DNTH | Dianthus Therapeutics Inc | 108.0K | $10.5M | $8.6M | 1.44% | +14.1K | 2026-06-30 |
| 17 | ALLO | Allogene Therapeutics Inc | 5.05M | $10.5M | $6.1M | 1.03% | +1.60M | 2026-06-30 |
| 18 | EYPT | Eyepoint Inc | 720.0K | $10.3M | $263K | 0.04% | -75,000 | 2026-06-30 |
| 19 | ARQT | Arcutis Biotherapeutics Inc | 370.0K | $9.7M | $11.8M | 1.98% | -30,645 | 2026-06-30 |
| 20 | CCCC | C4 Therapeutics Inc | 1.61M | $7.5M | $4.8M | 0.81% | -- | 2026-06-30 |
| 21 | IVA | Inventiva SA | 1.97M | $7.4M | $7.2M | 1.21% | -- | 2026-06-30 |
| 22 | KYMR | Kymera Therapeutics Inc | 47.5K | $5.4M | $5.5M | 0.92% | -52,500 | 2026-06-30 |
| 23 | SNSE | Faeth Therapeutics Inc | 175.1K | $4.4M | $4.4M | 0.74% | -- | 2026-06-30 |
← Scroll →